(Q45744777)

15 December 2017

title

Quantification of intrahepatic hepatitis B virus (HBV) DNA in patients with chronic HBV infection (English)

1 reference

15 December 2017

1 reference

1 reference

Cacciola I

1

1 reference

15 December 2017

Pollicino T

2

1 reference

15 December 2017

Squadrito G

3

1 reference

15 December 2017

Cerenzia G

4

1 reference

15 December 2017

Villari D

5

1 reference

15 December 2017

de Franchis R

6

1 reference

15 December 2017

Santantonio T

7

1 reference

15 December 2017

Brancatelli S

8

1 reference

15 December 2017

Colucci G

9

1 reference

15 December 2017

Raimondo G

10

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 February 2000

1 reference

15 December 2017

published in

Hepatology

1 reference

15 December 2017

volume

31

1 reference

15 December 2017

issue

2

1 reference

15 December 2017

page(s)

507-512

1 reference

15 December 2017

Spontaneous clearance and reactivation of hepatitis B virus infection among male homosexuals with chronic type B hepatitis

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310235

Reactivation of chronic hepatitis B virus infection by cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310235

Hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310235

7 January 2021

Chronic type B hepatitis and the "healthy" HBsAg carrier state

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310235

7 January 2021

The natural history of asymptomatic hepatitis B surface antigen carriers

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310235

7 January 2021

Active and inactive replication of hepatitis B virus deoxyribonucleic acid in chronic liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310235

7 January 2021

Persistence of "wild-type" and "e-minus" hepatitis B virus infection in chronic healthy HBsAg/anti-HBe positive carriers.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310235

7 January 2021

Hepatitis B virus (HBV) markers and HBV-DNA in serum and liver tissue of patients with acute exacerbation of chronic type B hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310235

7 January 2021

Reactivation of chronic type B hepatitis presenting as acute viral hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310235

7 January 2021

Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310235

7 January 2021

Natural course and response to interferon of chronic hepatitis B accompanied by antibody to hepatitis B e antigen

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310235

7 January 2021

A preliminary trial of lamivudine for chronic hepatitis B infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310235

7 January 2021

Hepatitis B reactivation after lamivudine

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310235

7 January 2021

Efficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B. Lamivudine Precore Mutant Study Group

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310235

7 January 2021

Detection of hepatitis B virus DNA directly in human serum by a simplified molecular hybridization test: comparison to HBeAg/anti-HBe status in HBsAg carriers.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310235

7 January 2021

Hepatitis B-DNA replication and histological patterns in liver biopsy specimens of chronic HBsAg positive patients with and without hepatitis delta virus superinfection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310235

7 January 2021

Hepatitis B E antigen detection in formalin-fixed liver biopsy specimens. A tool to investigate wild-type and E-minus variant HBV infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310235

7 January 2021

PreS and core gene heterogeneity in hepatitis B virus (HBV) genomes isolated from patients with long-lasting HBV chronic infection.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310235

7 January 2021

Severe outcome of hepatitis B virus (HBV) infection and lack of HBV e antigen-defective virus emergence in patients homozygous for HLA class I alleles

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310235

7 January 2021

Outcome of liver disease and response to interferon treatment are not influenced by hepatitis B virus core gene variability in children with chronic type B hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310235

7 January 2021

Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310235

7 January 2021

Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. Studies in percutaneous liver biopsies and post-mortem tissue specimens

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310235

7 January 2021

Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310235

7 January 2021

Presence of antibodies to the hepatitis B surface antigen is associated with an excess risk for hepatocellular carcinoma among non-Asians in Los Angeles County, California

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310235

7 January 2021

"Occult" hepatitis B virus as source of infection in liver transplant recipients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310235

7 January 2021

Recurrence of hepatitis B in children with serologic evidence of past hepatitis B virus infection undergoing antileukemic chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310235

7 January 2021

Hepatitis B virus persistence after recovery from acute viral hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310235

7 January 2021

Long-lasting memory T cell responses following self-limited acute hepatitis B

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310235

7 January 2021

Interrupted replication of hepatitis B virus in liver tissue of HBsAg carriers with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310235

7 January 2021

HBe antibody unrelated to 'e minus' hepatitis B virus variant infection in patients with chronic type D hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310235

7 January 2021

Identifiers

DOI

10.1002/HEP.510310235

1 reference

15 December 2017

PubMed ID

10655278

1 reference

15 December 2017